Clinical Trial Update: An Efficacy Study Of Ortataxel In Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on Ortataxel for recurrent glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Ortataxel

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED